Patents by Inventor Phillip Ordoukhanian

Phillip Ordoukhanian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Gene expression profiles associated with sub-clinical kidney transplant rejection
    Patent number: 12060611
    Abstract: By a genome-wide gene analysis of expression profiles of over 50,000 known or putative gene sequences in peripheral blood, the present inventors have identified a consensus set of gene expression-based molecular biomarkers associated with subclinical acute rejection (subAR). These genes sets are useful for diagnosis, prognosis, monitoring of subAR.
    Type: Grant
    Filed: September 12, 2019
    Date of Patent: August 13, 2024
    Assignees: THE SCRIPPS RESEARCH INSTITUTE, NORTHWESTERN UNIVERSITY
    Inventors: Daniel Salomon, John Friedewald, Sunil Kurian, Michael M. Abecassis, Steve Head, Phillip Ordoukhanian
  • METHODS AND COMPOSITIONS FOR SEQUENCING
    Publication number: 20210164128
    Abstract: Methods, compositions and kits are provided herein for insertional modification of nucleic acids by, for example transposase-mediated covalent insertion of insertion sequence into a sample nucleic acid molecule. Using sequence of the insertion to direct amplification of adjacent nucleic acid sequence, and using bar codes to map amplified sequence to partitions, one can map sample nucleic acid sequence to single molecules of the nucleic acid sample that are derived directly from the sample nucleic acid molecule.
    Type: Application
    Filed: February 9, 2021
    Publication date: June 3, 2021
    Inventors: Keith Brown, Daniel R. Salomon, Steven Head, Azeem Siddique, Phillip Ordoukhanian
  • Methods and compositions for sequencing
    Patent number: 10968536
    Abstract: Methods, compositions and kits are provided herein for insertional modification of nucleic acids by, for example transposase-mediated covalent insertion of insertion sequence into a sample nucleic acid molecule. Using sequence of the insertion to direct amplification of adjacent nucleic acid sequence, and using bar codes to map amplified sequence to partitions, one can map sample nucleic acid sequence to single molecules of the nucleic acid sample that are derived directly from the sample nucleic acid molecule.
    Type: Grant
    Filed: February 25, 2016
    Date of Patent: April 6, 2021
    Assignees: JUMPCODE GENOMICS, INC., THE SCRIPPS RESEARCH INSTITUTE
    Inventors: Keith Brown, Daniel R. Salomon, Steven Head, Azeem Siddique, Phillip Ordoukhanian
  • GENE EXPRESSION PROFILES ASSOCIATED WITH SUB-CLINICAL KIDNEY TRANSPLANT REJECTION
    Publication number: 20200208217
    Abstract: By a genome-wide gene analysis of expression profiles of over 50,000 known or putative gene sequences in peripheral blood, the present inventors have identified a consensus set of gene expression-based molecular biomarkers associated with subclinical acute rejection (subAR). These genes sets are useful for diagnosis, prognosis, monitoring of subAR.
    Type: Application
    Filed: September 12, 2019
    Publication date: July 2, 2020
    Inventors: Daniel Salomon, John Friedewald, Sunil Kurian, Michael M. Abecassis, Steve Head, Phillip Ordoukhanian
  • Gene expression profiles associated with sub-clinical kidney transplant rejection
    Patent number: 10443100
    Abstract: By a genome-wide gene analysis of expression profiles of over 50,000 known or putative gene sequences in peripheral blood, the present inventors have identified a consensus set of gene expression-based molecular biomarkers associated with subclinical acute rejection (subAR). These genes sets are useful for diagnosis, prognosis, monitoring of subAR.
    Type: Grant
    Filed: November 22, 2016
    Date of Patent: October 15, 2019
    Assignee: The Scripps Research Institute
    Inventors: Daniel R. Salomon, John Friedewald, Sunil Kurian, Michael M. Abecassis, Steve Head, Phillip Ordoukhanian
  • METHODS AND COMPOSITIONS FOR IN SILICO LONG READ SEQUENCING
    Publication number: 20180237950
    Abstract: Methods, compositions and kits are provided herein for insertional modification of nucleic acids by, for example transposase-mediated covalent insertion of insertion sequence into a sample nucleic acid molecule. Using sequence of the insertion to direct amplification of adjacent nucleic acid sequence, and using bar codes to map amplified sequence to partitions, one can map sample nucleic acid sequence to single molecules of the nucleic acid sample that are derived directly from the sample nucleic acid molecule.
    Type: Application
    Filed: February 25, 2016
    Publication date: August 23, 2018
    Inventors: Keith Brown, Daniel R. Salomon, Steven Head, Azeem Siddique, Phillip Ordoukhanian
  • GENE EXPRESSION PROFILES ASSOCIATED WITH SUB-CLINICAL KIDNEY TRANSPLANT REJECTION
    Publication number: 20170137885
    Abstract: By a genome-wide gene analysis of expression profiles of over 50,000 known or putative gene sequences in peripheral blood, the present inventors have identified a consensus set of gene expression-based molecular biomarkers associated with subclinical acute rejection (subAR). These genes sets are useful for diagnosis, prognosis, monitoring of subAR.
    Type: Application
    Filed: November 22, 2016
    Publication date: May 18, 2017
    Inventors: Daniel R. Salomon, John Friedewald, Sunil Kurian, Michael M. Abecassis, Steven Head, Phillip Ordoukhanian